Medifast (MED) Current Deferred Revenue (2018 - 2020)

Medifast's Current Deferred Revenue history runs 3 years deep, the most recent figure standing at $7.6 million for Q4 2020.

• Quarterly Current Deferred Revenue rose 75.54% year-over-year to $7.6 million in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $7.6 million (up 75.54% YoY) and the FY2020 annual result came in at $7.6 million, up 75.54% from the prior year.
• Current Deferred Revenue was $7.6 million for Q4 2020 at Medifast, up from $4.3 million in the prior quarter.
• Across five years, Current Deferred Revenue topped out at $7.6 million in Q4 2020 and bottomed at $2.8 million in Q4 2018.
• A 3-year average of $4.9 million and a median of $4.3 million in 2019 frame the typical range for Current Deferred Revenue.
• Annual changes were most pronounced in 2019 — Current Deferred Revenue surged 54.92% — and 2020, when it surged 75.54%.
• Medifast's Current Deferred Revenue stood at $2.8 million in 2018, then jumped by 54.92% to $4.3 million in 2019, then jumped by 75.54% to $7.6 million in 2020.
• Business Quant data shows MED's Current Deferred Revenue at $7.6 million in Q4 2020, $4.3 million in Q4 2019, and $2.8 million in Q4 2018.